Wednesday, November 27, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
@NCI
CoronaVirus

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in...

Editor / Curator -
Issam Radd
2021 Watch List

Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

Editor / Curator -
psychedelic stock review
Psychedelic News

CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).

Editor / Curator -
Biotech Stock Review
Biotech News

Discontinuing Coverage of PetVivo (PETV), a Gain of 1,035%.

Editor / Curator -
Cyclerion CYCN, Biotech Stock Review
Biotech News

Adding Cyclerion Thera (CYCN) $3.75, to Biotech Stock Review Watch List.

Editor / Curator -
Biotech Stock Review. Citius, CTXR
Incubator

More Great News From Citius Pharma (CTXR).

Editor / Curator -
Tiki Hut Fund
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning.

Editor / Curator -
GBT Technologies, GTBC
Telehealth

Adding GBT Technologies (GTCH) to the Watch List.

Editor / Curator -
Stand Down

Video: The Coming Collapse Of Crypto! (Tether Again)

Editor / Curator -
Auris Medical, Altamira Therapeutics
Biotech News

Adding Auris Medical (EARS) $3.50 to Biotech Watch List.

Editor / Curator -
1...454647...93Page 46 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.